About Nex Bio
Nex Bio is a Healthcare company based in Lubin (Poland) founded in 2015. Next-generation DNA analysis services, including genotyping and sequencing, are offered. Nex Bio offers products and services including DNA Analysis and Sequencing Services. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is NEXBIO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ.
Company details
Nex Bio was founded in 2015 and is located in Lubin, Poland, within the genomics sector. Services provided include DNA identification, genotyping, ribotyping, gene expression analyses, and Sanger sequencing. Operations focus on next-generation DNA analysis for various applications. The Polish edition of the Chivas Venture award was received on January 26, 2017, with a nomination for the CESA award in 2016.
- Annual Revenue$75.41 K (USD)9as on Dec 31, 2022
- Net Profit-$53.7 K (USD)-420as on Dec 31, 2022
- EBITDA-$53.63 K (USD)-412as on Dec 31, 2022
- Latest Funding Round$11.72K (USD), Grant
Jun 2017
- Investors
Products & Services of Nex Bio
Nex Bio offers a comprehensive portfolio of products and services, including DNA Analysis and Sequencing Services.
Conducts analysis of DNA and RNA for research purposes
Performs DNA sequencing for agriculture and industrial needs
Funding Insights of Nex Bio
- Total Rounds 1
- Last Round Grant — $11,719
- First Round $11,719
(Jun 2017)
- Investors Count 1
All 1 funding rounds of Nex Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $11,719 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Nex Bio
Nex Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Chivas Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startup accelerator | chivas.com/the-venture/ | London, United Kingdom |
Investor details for Nex Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nex Bio
2 dated milestones of Nex Bio across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Nex Bio is founded.
- Funding First funding round of $12K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nex Bio
Nex Bio was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Nex Bio is headquartered in Lubin, Poland. It is registered at Lubin, Lower Silesian Voivodeship, Poland.
Annual revenue of Nex Bio is $75.41K as on Dec 31, 2022.
Nex Bio was founded in 2015 and is located in Lubin, Poland, within the genomics sector. Services provided include DNA identification, genotyping, ribotyping, gene expression analyses, and Sanger sequencing. Operations focus on next-generation DNA analysis for various applications. The Polish edition of the Chivas Venture award was received on January 26, 2017, with a nomination for the CESA award in 2016.
Nex Bio offers DNA Analysis and Sequencing Services.
Nex Bio has 1 investor. Key investors include Chivas Venture.
Nex Bio operates through Nexbio Spółka Z Ograniczoną Odpowiedzialnością.